Plain-English translation of NCT06624462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a specialized metabolic care clinic can help young adults with schizophrenia or bipolar disorder manage their weight and reduce their risk of heart disease. Many people taking antipsychotic medications experience weight gain and metabolic problems, which increase the risk of serious health complications. This study will compare whether patients who receive care from a specialized metabolic clinic—with regular check-ins and personalized treatment plans—do better at losing weight and improving their overall health than those receiving standard care.
People with schizophrenia and bipolar disorder often have shorter lifespans and higher rates of heart disease, largely due to weight gain and metabolic problems caused by their psychiatric medications. Current mental health care often doesn't adequately address these physical health risks, so this trial is testing whether a dedicated metabolic care clinic can fill that gap.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the specialized metabolic clinic, you will visit this clinic for 12 months to receive focused care on weight management and heart health. You will have at least three measurement visits—at the start, after 6 months, and after 12 months—where your weight, blood pressure, blood sugar, and other health markers will be checked. If you are assigned to standard care, you will continue seeing your regular psychiatrist or general practitioner as usual, with measurements taken at the beginning and end of the 12-month study period.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Denmark